PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established ...

The House Task Force on Artificial Intelligence (AI) released a comprehensive 253-page report providing a roadmap for Congress as it develops ...

can predict early treatment efficacy in adult Chagas patients, suggesting that MultiCruzi could serve as an endpoint in future clinical trials.

US woman has gene-edited pig-kidney transplant, and scientists hope experimental surgery could save thousands of lives ...

Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...

The most-read articles addressing mental health in 2024 spanned therapeutic advancements, research discoveries, and insight ...

Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmac ...

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the “Company”, an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is ...

Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration ...

After two recent deaths in gene therapy clinical trials, the industry needs to be more open to sharing information to protect ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...